Published in Int J Radiat Oncol Biol Phys on August 01, 1999
Management of complications of prostate cancer treatment. CA Cancer J Clin (2008) 1.91
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer. World J Urol (2006) 1.03
Brachytherapy with permanent seed implantation. Int J Clin Oncol (2007) 0.94
Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer. Front Oncol (2014) 0.84
Treatment- and disease-related complications of prostate cancer. Rev Urol (2006) 0.84
Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last? J Urol (2012) 0.81
Serial changes of international prostate symptom score following I-125 prostate brachytherapy. Int J Clin Oncol (2006) 0.79
Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm(3)). Radiat Oncol (2014) 0.79
Acute urinary morbidity following I-125 prostate brachytherapy. Int J Clin Oncol (2005) 0.79
Permanent interstitial brachytherapy for prostate cancer: a current review. World J Urol (2003) 0.78
Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review. Radiat Oncol (2015) 0.78
Changes in lower urinary tract symptoms after prostate brachytherapy. J Contemp Brachytherapy (2011) 0.77
Acute urinary morbidity after a permanent 125I implantation for localized prostate cancer. J Radiat Res (2014) 0.77
Downsizing and prostate cancer. Rev Urol (2004) 0.77
Long term outcome and side effects in patients receiving low-dose I125 brachytherapy: a retrospective analysis. Int Braz J Urol (2016) 0.75
125 Gy or 135 Gy? Comments on the American Brachytherapy Society article by Beyer et al. IJROBP 2000;47:273-275. Int J Radiat Oncol Biol Phys (2001) 0.75
Effect of pretreatment prostate volume on urinary quality of life following intensity-modulated radiation therapy for localized prostate cancer. Res Rep Urol (2013) 0.75
Optimal management of prostate cancer with lethal biology - state-of-the-art local therapy. Asian J Androl (2015) 0.75
Clinical efficacy of combination therapy with an alpha blocker and low-dose sildenafil on post-therapy lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer. World J Urol (2016) 0.75
Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy. World J Urol (2013) 0.75
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys (2000) 4.99
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA (2001) 4.54
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med (2000) 4.39
Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys (1994) 4.13
Risk factors for the sexual transmission of genital herpes. Ann Intern Med (1992) 3.89
Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med (1994) 3.83
Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ (1994) 3.71
Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med (1991) 3.19
Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72
Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys (1996) 2.70
Chronic fatigue. A prospective clinical and virologic study. JAMA (1990) 2.54
Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA (1994) 2.03
Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med (1989) 2.03
Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med (1993) 2.01
Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst (1990) 1.92
Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm Dis (1999) 1.88
Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med (1994) 1.77
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology (2001) 1.76
Isotope selection for patients undergoing prostate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 1.71
Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J Med Virol (1985) 1.71
Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med (1991) 1.69
IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65
Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med (1998) 1.63
Comparison of mechanized anterior capsulectomy and manual continuous capsulorhexis in pediatric eyes. J Cataract Refract Surg (1994) 1.61
Serotypes and electropherotypes of human rotavirus in the USA: 1987-1989. J Infect Dis (1990) 1.54
Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med (1995) 1.52
Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood (1994) 1.51
Gene knockout of the alpha6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol (1997) 1.50
Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol (1992) 1.49
Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis (1988) 1.44
Clinically relevant optimization of 3-D conformal treatments. Med Phys (1992) 1.42
Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol (1993) 1.42
Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys (1997) 1.42
Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg (1994) 1.41
Patient satisfaction after LASIK for myopia. CLAO J (2001) 1.41
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol (1999) 1.39
Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis (1996) 1.36
Mobile e-health: the unwired evolution of telemedicine. Telemed J E Health (2003) 1.35
Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ (2001) 1.32
LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission. J Virol (2001) 1.26
A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma (2009) 1.24
A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys (2001) 1.24
Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol (1999) 1.22
Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study. Circulation (2000) 1.22
Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy. J Clin Oncol (2000) 1.19
Comparison of neutralization and DNA restriction enzyme methods for typing clinical isolates of human adenovirus. J Clin Microbiol (1985) 1.18
Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol (1988) 1.18
The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev (1996) 1.17
Use of green fluorescent protein (GFP) to study the invasion pathways of Edwardsiella tarda in in vivo and in vitro fish models. Microbiology (2000) 1.16
Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2000) 1.14
Comparative proteomic analysis of extracellular proteins of enterohemorrhagic and enteropathogenic Escherichia coli strains and their ihf and ler mutants. Appl Environ Microbiol (2004) 1.13
In vitro and in vivo effects of deferoxamine in neonatal acute leukemia. Blood (1987) 1.13
Isolation and characterization of six new genome types of human adenovirus types 1 and 2. J Clin Microbiol (1985) 1.12
Contamination of polycyclic aromatic hydrocarbons in surface sediments of mangrove swamps. Environ Pollut (2001) 1.11
Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection. J Infect Dis (1988) 1.11
Sexually transmitted infections in female sex workers: reduced by condom use but not by a limited periodic examination program. Sex Transm Dis (1998) 1.11
Enhancement of somatic intrachromosomal homologous recombination in Arabidopsis by the HO endonuclease. Plant Cell (1996) 1.11
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol (1997) 1.11
Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis (1992) 1.11
A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood (1989) 1.09
Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J Infect Dis (1990) 1.09
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol (1996) 1.08
Microanatomic clonality of gamma delta T cells in human leishmaniasis lesions. J Immunol (1992) 1.08
Routine typing of herpes simplex virus isolates. Diagn Microbiol Infect Dis (1985) 1.07
Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol (1990) 1.07
Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot. J Clin Microbiol (1992) 1.06
Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120. Immunol Lett (2001) 1.05
Current trends in the use of intraocular lenses in children. J Cataract Refract Surg (1994) 1.04
Gastric DNA-binding proteins recognize upstream sequence motifs of parietal cell-specific genes. Proc Natl Acad Sci U S A (1993) 1.04
Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sex Transm Infect (2002) 1.03
Genome analysis of the moss Physcomitrella patens (Hedw.) B.S.G. Mol Gen Genet (1994) 1.03
Human T cell lymphotropic virus type I infection among female sex workers in Peru. J Infect Dis (1994) 1.02
Differential gene expression in nasopharyngeal carcinoma cells. Life Sci (2000) 1.02
Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract (2003) 1.01
Safety and efficacy of sub-antimicrobial-dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res (1998) 1.00
Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene (2004) 1.00
Mannosylphosphate transfer to cell wall mannan is regulated by the transcriptional level of the MNN4 gene in Saccharomyces cerevisiae. FEBS Lett (1997) 0.99
Comparative proteomic analysis of extracellular proteins of Edwardsiella tarda. Infect Immun (2002) 0.99
Green fluorescent protein-tagged Edwardsiella tarda reveals portal of entry in fish. FEMS Microbiol Lett (2001) 0.98
Identification of asbestos in human tissues. J Occup Med (1973) 0.97
Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. J Trauma (1992) 0.97
Experience and extensions to the ASM2 family of models. Water Sci Technol (2002) 0.97
Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives. J Androl (1998) 0.97
Changes of blood humoral substances in experimental cirrhosis and their effects on portal hemodynamics. Chin Med J (Engl) (1990) 0.97
Cloning, nucleotide sequences, and enzymatic properties of glucose dehydrogenase isozymes from Bacillus megaterium IAM1030. J Bacteriol (1992) 0.97
Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. Cancer Res (2001) 0.96
Isolation of a funnel-web spider polypeptide with homology to mamba intestinal toxin 1 and the embryonic head inducer Dickkopf-1. Toxicon (2000) 0.96
Asymptomatic maternal shedding of herpes simplex virus at the onset of labor: relationship to preterm labor. Obstet Gynecol (1996) 0.96
The dissemination of cancer by transurethral resection of locally advanced prostate cancer. J Urol (1983) 0.95
Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis (1999) 0.95
Peroxiredoxins in colorectal neoplasms. Histol Histopathol (2010) 0.95